First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after ...

"I was moved to invent the Saving Lives Shield after watching daily world news reports of mass shootings in schools, churches ...

"I wanted to create a new mobile hunting shack with strategic windows for hidden and quiet hunting," said an inventor, from ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today highlighted pipeline ...

The dual inhibition of PD-1 and VEGF pathways by ivonescimab aims to enhance immune response and limit tumor angiogenesis, ...

A snapshot of life in wintry Iceland has gained attention online, with the clip showing Vitalijus Barauskas’s car completely ...

(Alliance News) - Hutchmed China Ltd on Wednesday said the results from its SACHI phase-three lung cancer trial have been published in medical journal the Lancet.

EXEL posts approximately $2.32B in 2025 revenues and guides $2.525 -$2.625B for 2026 as Cabometyx grows and a zanzalintinib ...

Houston, Texas-based carrier Avelo Airlines announced this month that it will stop providing deportation flights for ...

As part of the changes, Avelo will close its bases in Mesa, Ariz. (AZA); Raleigh-Durham (RDU); and Wilmington (ILM).

Avelo Airlines said it was closing three of its bases and reconsolidating its network around the remaining four as it seeks ...

As part of its fleet streamlining efforts, Avelo will be retiring six Boeing 737-700 aircraft, representing the majority of ...